A review of augmentation therapy for alpha-1 antitrypsin deficiency

Medicine & Life Sciences

• alpha 1-Antitrypsin Deficiency 100%
• Emphysema 32%
• alpha 1-Antitrypsin 25%
• United States Food and Drug Administration 19%
• Secretory Proteinase Inhibitory Proteins 15%
• Drug Approval 12%
• Therapeutics 11%
• Expert Testimony 10%
• Polymerization 10%
• Intravenous Infusions 9%
• Autophagy 9%
• Genetic Therapy 9%
• Liver Cirrhosis 9%
• Cost-Benefit Analysis 8%
• Drug Therapy 5%
• Lung 5%

Chemical Compounds

• Trypsin Inhibitor 82%
• Plasma 4%
• Polymerization Reaction 4%
• Drug 4%
• Molecule 2%